• May 26, 2015

Jubilant Cadista Pharmaceuticals breaks ground in Salisbury, plans to hire up to 200 - The Star Democrat - Easton, Maryland: Business

Jubilant Cadista Pharmaceuticals breaks ground in Salisbury, plans to hire up to 200

Print
Font Size:
Default font size
Larger font size

Posted: Tuesday, July 23, 2013 6:00 am | Updated: 9:40 am, Tue Jul 23, 2013.

BALTIMORE — Maryland Department of Business and Economic Development Secretary Dominick Murray July 19 joined Salisbury Mayor James Ireton Jr., and officials from Jubilant Cadista Pharmaceuticals, a generic prescription pharmaceuticals company, to break ground on an expansion of the company’s U.S. headquarters in Salisbury.

The expansion, which will be completed in fourth quarter of 2014, will double the company’s facility and include additional space for production, packing, warehouse and distribution, enabling it to double the number of products it produces. In addition, the company, which grew its employment base from 30 in 2005 to 300 this year, plans to add as many as 200 employees over the next five years.

Plans for the expansion were announced in November 2011 as part of Gov. Martin O’Malley’s trade mission to India, after the governor met with officials from the company’s India-based parent Jubilant Life Sciences, part of the Jubilant Group.

“It is a testament to our outstanding workforce and supportive climate for life sciences companies that a world-class company like Cadista Pharmaceuticals has chosen to expand and add jobs on our Eastern Shore,” said O’Malley. “Our trade mission to India — the first by a sitting Maryland Governor — was a tremendous success. We brought home more than $60 million in business deals for Maryland companies and we are continuing to see companies, like Cadista, invest in Maryland.”

“When our parent company, Jubilant Life Sciences Limited, acquired a majority stake in this company eight years ago, there were about 30 people working here,” said Scott Delaney, CEO of Jubilant Cadista. “Today, nearly 300 employees help to produce 14 product families at this facility. The site expansion will allow us to grow and accommodate our plans of doubling the number of products over the next two years. During the next several years, the addition of these and possibly more products currently in the pipeline will open opportunities for the addition of up to 200 or more jobs. This kind of rapid growth could not, and cannot, happen without tremendous support from our parent company and the encouragement of the city of Salisbury, Wicomico County and the State of Maryland.”

“Cadista has put Salisbury on the map at an international level. A big thank you to the Bhartia family, Gov. Martin O’Malley, DBED, and the men and women who work in the local facility,” said Ireton. “As Salisbury and Maryland continue to lead the charge for economic recovery and job creation, we know that making business viable for companies like Cadista is the cornerstone of success. These jobs and the ones that follow are important in the growth of Salisbury’s economic base.”

Cadista Holdings Inc., along with its fully owned subsidiary Jubilant Cadista Pharmaceuticals, develops, manufactures, sells and distributes prescription generic pharmaceutical products in the United States. The company specializes in the formulation of generic prescription medications in both tablets and capsules that come in sustained release and immediate release forms. For more information, visit www.cadista.com.

The Maryland Department of Business and Economic Development stimulates private investment and creates jobs by attracting new businesses, encouraging the expansion and retention of existing companies, and providing workforce training and financial assistance to Maryland companies. The Department promotes the state’s many economic advantages and markets local products and services at home and abroad to spur economic development and international investment, trade and tourism.

For more information, visit www.ChooseMaryland.org.

More about

More about

More about

More about

Welcome to the discussion.

Connect With Us

Today's e-Edition

Bonus Section

Twitter

Featured Ads